We are thrilled to announce that Dr. Deepa K. Tiku and Amrish Tiwari, esteemed Partners at our firm, have been recognized by the prestigious IAM Strategy 300 as two of the world’s top Intellectual Property (IP) strategists.
This accolade marks a consecutive third-year ranking for Dr. Deepa K. Tiku, Partner, and an impressive sixth-time recognition for Amrish Tiwari, Partner and Practice Lead for Life Sciences and Chem-Pharma. Earlier this year, Amrish was also honored by IAM Patent 1000 in June.
Dr. Deepa K. Tiku has been acknowledged for her outstanding contributions in the fields of biotechnology, chemicals, medical devices, pharmaceuticals, and life sciences. Her dual expertise as an experienced IP professional and dedicated life sciences researcher positions her as a trusted advisor to both domestic and international clients in the life sciences industry.
Amrish Tiwari, recognized for his expertise in biotechnology, chemicals, energy, materials, medical devices, and pharmaceuticals, has consistently demonstrated exceptional skill in handling complex IP matters across diverse life sciences domains. His extensive experience as a patent professional makes him a valued strategist for organizations navigating challenging IP landscapes.
The IAM Strategy 300 is a globally recognized resource that identifies professionals who excel in elevating IP portfolio management and delivering unparalleled strategic advice. Inclusion in this guide is the result of thorough research, highlighting only the most distinguished individuals in the field.
Congratulations to Dr. Deepa K. Tiku and Amrish Tiwari on this well-deserved recognition. Their achievements reflect their dedication to excellence in the field of intellectual property.